Phase I Trial of Lenalidomide in Pediatric Patients With Recurrent, Refractory, or Progressive Primary CNS Tumors: Pediatric Brain Tumor Consortium Study PBTC-018

PURPOSE: A phase I trial of lenalidomide was performed in children with recurrent, refractory, or progressive primary CNS tumors to estimate the maximum-tolerated dose (MTD) and to describe the toxicity profile and pharmacokinetics. PATIENTS AND METHODS: Lenalidomide was administered by mouth daily...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Warren, Katherine E., Goldman, Stewart, Pollack, Ian F., Fangusaro, Jason, Schaiquevich, Paula, Stewart, Clinton F., Wallace, Dana, Blaney, Susan M., Packer, Roger, MacDonald, Tobey, Jakacki, Regina, Boyett, James M., Kun, Larry E.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2011
Fag:
Original Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3056466/
https://ncbi.nlm.nih.gov/pubmed/21149652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.3601
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker